SLC7A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.400200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.994510E-04 |
Normal-vs-Stage2 |
6.00099999999992E-05 |
Normal-vs-Stage3 |
7.461100E-03 |
Normal-vs-Stage4 |
3.184800E-01 |
Stage1-vs-Stage2 |
7.103200E-01 |
Stage1-vs-Stage3 |
2.446600E-01 |
Stage1-vs-Stage4 |
3.202600E-01 |
Stage2-vs-Stage3 |
1.378240E-01 |
Stage2-vs-Stage4 |
1.629040E-01 |
Stage3-vs-Stage4 |
4.154600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.73220000021912E-07 |
Normal-vs-AfricanAmerican |
2.352800E-01 |
Normal-vs-Asian |
3.614300E-02 |
Caucasian-vs-AfricanAmerican |
3.619700E-02 |
Caucasian-vs-Asian |
6.295200E-01 |
AfricanAmerican-vs-Asian |
2.908000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.43690000190489E-08 |
Normal-vs-Female |
7.453600E-02 |
Male-vs-Female |
7.303700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.809210E-01 |
Normal-vs-Extreme_Weight |
1.43189999968207E-07 |
Normal-vs-Obese |
4.16890000000114E-05 |
Normal-vs-Extreme_Obese |
5.959000E-04 |
Normal_Weight-vs-Extreme_Weight |
6.447700E-02 |
Normal_Weight-vs-Obese |
4.083800E-01 |
Normal_Weight-vs-Extreme_Obese |
8.982400E-02 |
Extreme_Weight-vs-Obese |
2.082400E-03 |
Extreme_Weight-vs-Extreme_Obese |
9.941200E-01 |
Obese-vs-Extreme_Obese |
1.645980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.554600E-01 |
Normal-vs-Age(41-60Yrs) |
4.32019999774269E-08 |
Normal-vs-Age(61-80Yrs) |
8.29280000000931E-05 |
Normal-vs-Age(81-100Yrs) |
1.23629999571051E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.153810E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.548400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.522600E-03 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.663600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.239500E-04 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.083960E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
6.90550000514989E-08 |
Normal-VS-Type2 PRCC |
1.832550E-04 |
Normal-VS-KIRP CIMP |
1.187830E-01 |
Normal-VS-Unclassified PRCC |
1.029170E-04 |
Type1 PRCC-VS-Type2 PRCC |
8.636400E-03 |
Type1 PRCC-VS-KIRP CIMP |
4.046800E-04 |
Type1 PRCC-VS-Unclassified PRCC |
3.444300E-03 |
Type2 PRCC-VS-KIRP CIMP |
1.042360E-04 |
Type2 PRCC-VS-Unclassified PRCC |
9.687800E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.803440E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.81669999990797E-07 |
Normal-vs-N1 |
8.517700E-02 |
Normal-vs-N2 |
7.546800E-01 |
N0-vs-N1 |
1.975890E-03 |
N0-vs-N2 |
3.801600E-01 |
N1-vs-N2 |
7.941800E-01 |
|
|